Received: 22 June 2020
Accepted: 1 July 2020
First Online: 9 July 2020
Ethics approval and consent to participate
: Ethics committee approved the post hoc analysis of these data for scientific purposes.The study drug for this study is approved by the European Medical Association [EMA], but not yet commercialized.
: Not applicable.
: The authors declare that they have no competing interest.